5-HTP: Real Evidence, Real Risk — Why We're Cautious

5-HTP (5-hydroxytryptophan) is one of the more pharmacologically real supplements on the market — it's a direct precursor to serotonin, and there is genuine clinical trial evidence behind it. It's also one of the few supplements where the honest, evidence-based answer isn't just "does it work" but "is it safe for you specifically." Here's what the research shows on both sides — and why the one product of ours that contains it carries the warning it does.

What 5-HTP is and why it's different from most supplements

Most nervous-system supplements act indirectly — supporting a pathway, replenishing a cofactor, modulating stress hormones. 5-HTP is more direct: your body converts it straight into serotonin, the neurotransmitter most associated with mood regulation. That directness is exactly what gives it real trial evidence for mood and sleep support, and it's also exactly what creates its safety profile. A supplement that reliably does something to brain chemistry is, by definition, a supplement that can interact with anything else touching the same chemistry.

The evidence for it

5-HTP has been studied for depression and mood since the 1970s, including head-to-head comparisons against prescription antidepressants such as fluoxetine.⁵ A 2019 systematic review and meta-analysis in Nutrition Reviews screened 13 investigations of 5-HTP across different types of depression and pooled seven of them.¹ It reported a depression remission rate of 0.65 (95% CI, 0.55–0.78) and a large effect on depression questionnaires (Hedges' g 1.11; 95% CI, 0.53–1.69) — a real signal, on paper.

Read the limitations next to that effect size, though, because they are the whole story. Heterogeneity between the pooled trials was high (I² = 76%), driven by differing treatment durations, depression subtypes, study designs and doses. Most importantly, the review's authors flagged that few of the included studies had a placebo group at all, which downgraded study quality on their risk-of-bias assessment, and they closed by calling for future work that actually uses placebo controls and well-defined diagnoses. A large pooled effect drawn mostly from trials without a placebo arm is not the same class of evidence as a large pooled effect from placebo-controlled trials — depression symptom scores improve substantially on placebo alone, so an uncontrolled before-and-after design systematically flatters whatever is being tested. That is the honest version: the mechanism is direct, the early trials are real, and the evidence is weaker than its headline effect size looks. This is still a genuinely different picture from most "mood support" ingredients we review — the question here is trial design and modern replication, not whether the ingredient does anything at all. For how we weigh that kind of evidence generally, see why we don't sell "brain blends".

It's worth being precise about what "comparable to fluoxetine" actually means, because the phrase does a lot of work in 5-HTP marketing. The trial most often cited for it enrolled 60 patients in India presenting with a first depressive episode and titrated 5-HTP up to 400mg/day against fluoxetine up to 40mg/day over four weeks, running eight weeks in total.⁵ At eight weeks, symptom scores had fallen by roughly 58% on 5-HTP and 64% on fluoxetine, with a positive response in 73% and 80% of patients respectively. Doses across the wider trial literature vary considerably — the pooled review names differing doses as one of the sources of its high heterogeneity, alongside differing durations, designs and depression subtypes.¹ We are not going to print a "commonly used range" here: the only source we had for one was a consumer drug database, and it is not a number anyone should be self-selecting a serotonin precursor from.

Two things that comparison is not. It had no placebo arm — so it establishes that 5-HTP performed similarly to fluoxetine in 60 people, not that either beat placebo in this sample, and 58% versus 64% in 60 patients is a difference this trial was far too small to rule in or out. And it is a single-centre trial in one country, not a replicated finding. It's evidence that the serotonin-precursor mechanism is a real one, tested in real people, with real trial data behind it — a higher bar than most "mood support" ingredients on the market ever clear. It is not evidence that 5-HTP works faster, works better, or substitutes for a clinician-managed treatment plan.

A history worth knowing: the 1989 outbreak and "Peak X"

5-HTP's safety story doesn't start with modern drug interactions — it starts with a manufacturing failure. In 1989, a contaminated batch of L-tryptophan (5-HTP's chemical cousin, also a serotonin precursor sold as a supplement) caused an outbreak of eosinophilia-myalgia syndrome (EMS) in the United States, a severe and sometimes fatal condition involving extreme muscle pain and abnormal white blood cell counts. That outbreak sickened more than 1,500 people and caused at least 30 deaths.² Researchers eventually traced it to a specific manufacturing-process contaminant, later characterised and nicknamed "Peak X" for the extra peak it produced on lab chromatography readouts.³ The episode led to a temporary FDA ban on tryptophan supplements and reshaped how manufacturers and regulators think about amino-acid-derived supplements in general, 5-HTP included, since it is made by a related fermentation and extraction process. It is also why HPLC screening for Peak X became standard practice in this category — a legacy of one bad manufacturing run three decades ago that still shapes how this category is (and should be) tested. We previously described that screening as a regulatory requirement, sourced to a consumer drug database; we could not verify it as a formal requirement at source, so it is described here as the industry practice it demonstrably is. Checking that kind of testing actually happened is what a certificate of analysis is for.

Two honest caveats on that history, because it is routinely told in both directions. The EMS outbreak itself has been attributed to contaminated L-tryptophan from one manufacturer — not to 5-HTP, and not to tryptophan as a molecule. And "Peak X" turns out not to be a single compound at all. Analytical work published in 1999 showed it is a family of contaminants sharing the same molecular weight (234 Da) and similar chromatographic behaviour — and that all eight commercially available 5-HTP samples the authors tested contained three or more members of that family.⁶ Its structure was characterised in more detail in 2003.³ What has never been established is that any member of the Peak X family actually caused EMS. So this is a manufacturing-quality story with a genuinely unsettled chemistry chapter in the middle of it, not a reason to treat either compound as inherently toxic. We're including it because it explains why the testing requirements exist, not because it is evidence against the ingredient.

The safety problem: serotonin syndrome

Serotonin syndrome is a genuinely dangerous, well-documented condition that happens when serotonin activity in the body climbs too high — symptoms include a racing heart, high blood pressure, elevated body temperature, tremor, agitation, and in severe cases it can be life-threatening. Because 5-HTP raises serotonin directly, combining it with anything else that also raises serotonin creates real risk. Poison Control documents one published case of exactly this combination: a 33-year-old woman who took seven 5-HTP tablets while on sertraline and developed nausea, diarrhoea, agitation, hallucinations, tremor, sweating, muscle spasms and a racing heart, needing three days in hospital.²

We want to be exact about what that case does and doesn't establish, since it is the single most-quoted 5-HTP safety anecdote on the internet. It is one case report, not a rate; it involved taking several tablets at once rather than a label dose; and the number of people who combine 5-HTP with an SSRI uneventfully is unknown, because nobody counts them. One case report cannot tell you how likely harm is. What it does establish is that the interaction is not theoretical — and an interaction that is real but of unquantified frequency is precisely the kind a bottle on a shelf is badly placed to manage. If you're already on psychiatric medication, our guide to Proco products and mental health medications is the piece to read before adding anything.

A 2024 study published in the peer-reviewed journal Toxics examined 112 patients admitted to a poison control centre for acute toxicity involving serotonergic ("5-HT modulator") agents — the same broad drug class 5-HTP belongs to pharmacologically.⁴ The researchers found that two-thirds of the patients who went on to develop serotonin syndrome had been exposed to long-term co-ingestion of multiple serotonergic substances, not a single large dose — which is exactly the everyday scenario that worries us with an over-the-counter 5-HTP bottle: someone quietly stacking it on top of a prescription they're already taking, day after day, rather than a single obvious overdose.

That list of substances that can combine with 5-HTP to raise serotonin is longer than most people expect, and it includes several things people don't think of as "medication" at all:

Poison Control names two of these categories directly — antidepressants, and migraine and pain medications that act on serotonin.² The tramadol and St. John's Wort rows are well-established serotonergic interactions documented elsewhere; St. John's Wort also appears on our own Sleep Support warning label for this reason, and we've written separately about why St. John's Wort makes us cautious.

Why 5-HTP isn't sold as a standalone product — safety, not evidence

5-HTP fits our category (sleep, mood-adjacent nervous-system support) and clears the evidence question outright — the reason it isn't sold as its own product is the interaction risk below, and safety gates every ingredient regardless of category fit.

This is a different kind of caution than most of our evidence rejections. 5-HTP isn't a weak-evidence ingredient — it's a strong-mechanism, real-effect ingredient with a genuine interaction risk that a supplement label and a bottle on a shelf cannot safely manage on its own. A meaningful share of adults take an SSRI or SNRI at some point, often without thinking of it as relevant to a "natural" sleep or mood supplement purchase.

The strength of the evidence isn't the problem with 5-HTP — the strength of the interaction is.

Selling 5-HTP over the counter, without a clinician actively screening for that overlap, isn't a risk we're willing to take with our name on the label — regardless of how real the underlying serotonin evidence is, and regardless of how well a given batch tests for legacy contaminants like Peak X. Manufacturing quality controls the purity of what's in the bottle; they don't control what's already in the customer's medicine cabinet, and that second variable is the one that actually causes harm.

This is also why we're cautious about the framing "natural, so it's gentler." 5-HTP is natural in the sense that it's a compound your body already produces on the way to making serotonin — but that's precisely what makes it pharmacologically active rather than inert. An ingredient doesn't get a safety pass for being upstream of a real neurotransmitter; if anything, that's the reason to take the interaction risk more seriously, not less.

5-HTP is currently in Sleep Support, named on the label but sitting inside a 14-ingredient botanical blend with a combined weight rather than an individually disclosed dose — precisely the scenario this article argues is hardest to reason about, since dose is what determines interaction risk. The serotonin-interaction warning is already on that label and product page: it names SSRIs, SNRIs, MAOIs, triptans, blood thinners, hormonal birth control, anticonvulsants, HIV medications and anti-rejection drugs, and it covers St. John's Wort in the same blend. What is not yet disclosed is the per-ingredient milligram amount, and we're not going to print a number we can't stand behind. Until per-ingredient disclosure is resolved with the manufacturer: if you take any medication affecting serotonin, don't take Sleep Support without checking with your doctor first. If full dose disclosure is what you want from a sleep product today, Sleep Formula is the one that has it — and it contains no 5-HTP and no St. John's Wort. Our guide to reading a supplement label explains why a combined blend weight limits what any reader can work out.

This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. 5-HTP can interact dangerously with antidepressants and other medications — do not take it without speaking to your doctor first, especially if you take any medication affecting serotonin.

References

1. Javelle, F., et al. "Effects of 5-hydroxytryptophan on distinct types of depression: a systematic review and meta-analysis." Nutrition Reviews, 2020, 78(1):77–88. academic.oup.com
2. "5-HTP safety concerns." Poison Control. poison.org
3. Sternberg, E.M., et al. "Structural characterization of a case-implicated contaminant, 'Peak X,' in commercial preparations of 5-hydroxytryptophan." Advances in Experimental Medicine and Biology, 2003. pubmed.ncbi.nlm.nih.gov
4. Sharif, A.F., et al. "Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators." Toxics, 2024, 12(8), 550. doi:10.3390/toxics12080550
5. Jangid, P., et al. "Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode." Asian Journal of Psychiatry, 2013, 6(1):29–34. pubmed.ncbi.nlm.nih.gov
6. Klarskov K, Johnson KL, Benson LM, Gleich GJ, Naylor S. Eosinophilia-myalgia syndrome case-associated contaminants in commercially available 5-hydroxytryptophan. Adv Exp Med Biol. 1999. doi:10.1007/978-1-4615-4709-9_58. See also Johnson KL, Klarskov K, Benson LM, Williamson BL, Gleich GJ, Naylor S. Presence of peak X and related compounds. J Rheumatol. 1999. pubmed.ncbi.nlm.nih.gov/10606395

If you want the wider version of this argument — what an ingredient has to clear before it earns a place on one of our labels, and how often the answer is "not yet" — it's in why we don't sell "brain blends", and the companion question of whether a supplement belongs in an anxiety or low-mood plan at all is covered in can supplements help with anxiety and low mood.

We hold every ingredient in the Proco range to the same bar: dosed at the level the human trials actually used, with a safety profile that's clean at that dose. 5-HTP does not clear that bar inside a combined blend, and we're pressing our manufacturer for per-ingredient disclosure on Sleep Support rather than claiming it already exists. Explore the current range at procohq.com.